116 related articles for article (PubMed ID: 2089448)
21. [Susceptibility to antibiotics of Staphylococcus aureus strains isolated from pus specimens obtained from patients referred for autovaccine therapy].
Ekiel A; Kapp-Burzyńska Z; Rogala-Zawada D; Kłaptocz B; Wilk I
Med Dosw Mikrobiol; 1995; 47(3-4):127-32. PubMed ID: 8833923
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial susceptibility profiles of Pseudomonas aeruginosa and Staphylococcus aureus isolated in Italy from patients with hospital-acquired infections.
Blandino G; Marchese A; Ardito F; Fadda G; Fontana R; Lo Cascio G; Marchetti F; Schito GC; Nicoletti G
Int J Antimicrob Agents; 2004 Nov; 24(5):515-8. PubMed ID: 15519488
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of mupirocin and amoxicillin-clavulanate alone and in combination against staphylococci including those resistant to methicillin.
Alou L; Cafini F; Sevillano D; Unzueta I; Prieto J
Int J Antimicrob Agents; 2004 May; 23(5):513-6. PubMed ID: 15120734
[TBL] [Abstract][Full Text] [Related]
24. Comparative in vitro activity of amoxycillin/clavulanate (augmentin), ceftazidime and ceftriaxone against hospital strains of gram-negative and -positive bacteria.
Abd-Elalim Eltahawy AT; Khalaf RM
Chemioterapia; 1988 Apr; 7(2):75-8. PubMed ID: 3293818
[TBL] [Abstract][Full Text] [Related]
25. Microbiological indications for the treatment of Staphylococcus aureus infections.
Fabbri A; Tacchella A; Belli ML; Losurdo G
Chemioterapia; 1988 Dec; 7(6):378-81. PubMed ID: 3219748
[TBL] [Abstract][Full Text] [Related]
26. The efficacy of amoxycillin/clavulanate (Augmentin) in the treatment of severe staphylococcal infections.
Moreillon P
J Chemother; 1994 Apr; 6 Suppl 2():51-7. PubMed ID: 7799055
[TBL] [Abstract][Full Text] [Related]
27. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats.
Cantoni L; Wenger A; Glauser MP; Bille J
J Infect Dis; 1989 May; 159(5):989-93. PubMed ID: 2708846
[No Abstract] [Full Text] [Related]
28. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B
J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
[TBL] [Abstract][Full Text] [Related]
29. [Sensitivity profile of 147 strains of S. aureus isolated from patients in continuous ambulatory peritoneal dialysis].
Leme IL; Sesso Rde C; Castelo Filho A; Begliomini SR; Draibe S; Ajzen H
Rev Paul Med; 1989; 107(4-6):219-22. PubMed ID: 2640507
[TBL] [Abstract][Full Text] [Related]
30. Sensitivity of clinical isolates from German hospitals to amoxicillin/clavulanic acid (Augmentin) compared with other antibiotics.
Focht J; Klietmann W; Nösner K; Rolinson GN; Johnsen J
Chemotherapy; 1988; 34(4):332-40. PubMed ID: 3264780
[TBL] [Abstract][Full Text] [Related]
31. [Bacterial strains isolated in high nosocomial risk departments].
Muntean D; Moldovan R; Licker M; Dan L; Crăciunescu M; Hogea E; Dumitraşcu V; Orb E; Iancu A; Bădiţoiu L; Amăricăi E; Ghiriş MF; Horhat FG; Berceanu-Văduva D
Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):118-22. PubMed ID: 15341325
[TBL] [Abstract][Full Text] [Related]
32. [Methicillin-resistant Staphylococcus aureus (MRSA) infection--significance of MRSA in respiratory tract infection].
Shigeno Y; Yamashiro T; Kusano N
Rinsho Byori; 1990 Sep; 38(9):1005-15. PubMed ID: 2232262
[TBL] [Abstract][Full Text] [Related]
33. [A clinical study of respiratory infection with methicillin-resistant Staphylococcus aureus (MRSA)].
Niimi T; Hasegawa Y; Sugiura Y; Iijima N; Yoshikawa K; Nishiwaki H; Morishita M
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jul; 31(7):809-15. PubMed ID: 8366619
[TBL] [Abstract][Full Text] [Related]
34. [Escherichia coli strains isolated from the urine of children with urinary tract infections and their antibiotic susceptibility. A comparative study from three centers].
Köksal I; Mocan H; Berkman E; Saltoğlu N
Mikrobiyol Bul; 1990 Jul; 24(3):241-7. PubMed ID: 2283975
[TBL] [Abstract][Full Text] [Related]
35. [Antibiotic sensitivity of Staph. aureus strains isolated from the upper respiratory tracts of healthy carriers].
Ternovskaia LN
Antibiotiki; 1977 Jun; 22(6):516-8. PubMed ID: 883796
[TBL] [Abstract][Full Text] [Related]
36. [Phage-typing in the surveillance of hospital infections: tests on strains of Staphylococcus aureus].
Moiraghi Ruggenini A; Vanini GC; Maury F; Grassi R; Garella D
G Batteriol Virol Immunol; 1983; 76(7-12):218-26. PubMed ID: 6241575
[TBL] [Abstract][Full Text] [Related]
37. [Are we being threatened by multiresistant strains of Staphylococcus aureus?].
Aepfelbacher M
MMW Fortschr Med; 2005 Jan; 147(4):33-5, 37. PubMed ID: 15745339
[TBL] [Abstract][Full Text] [Related]
38. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
Li JT; Li Y; Wang J;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911
[TBL] [Abstract][Full Text] [Related]
39. An outbreak of Staphylococcus aureus strains with reduced susceptibility to glycopeptides in a French general hospital.
Pina P; Marliere C; Vandenesch F; Bedos JP; Etienne J; Allouch PY
Clin Infect Dis; 2000 Nov; 31(5):1306-8. PubMed ID: 11073773
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial resistance of Staphylococcus aureus and oral streptococci strains from high-risk endocarditis patients.
Groppo FC; Castro FM; Pacheco AB; Motta RH; Filho TR; Ramacciato JC; Florio FM; Meechan JG
Gen Dent; 2005; 53(6):410-3. PubMed ID: 16366048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
